Skip to main content
Equibles
USNA logo

USNA · Usana Health Sciences Inc

Track USNA — free

Use USNA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about USNA

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$13.18 -0.07 (-0.53%) At close · Aug 20
Market Cap
$243.52M
Shares
18.48M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.18 Open$13.20 Day$12.93–13.34 52W close$12.86–32.24 Avg vol 30d182K Short int690K · 3.7% float · 7.5d Short vol40% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 10 wks
FQ3-27 quarter ends
~Oct 3, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −32%
      below
      Price vs 50-day avg −32%
      below
      RSI (14) 27
      oversold
      MACD trend Negative
      52-week position 2%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −37%
      trailing
      6-month return −39%
      trailing
      YTD return −33%
      this year
      Relative strength −50%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $19 › 200d $19 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +23 funds added
      Insider flow Distributing
      Net -$524.2K over 90 days · 100% sells
      Short interest Falling
      3.74% of float · ▼ -8.3% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      137 holders — mid 3-yr range
      Squeeze score 53
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −11%
      Y/Y
      Gross margin 68%
      expanding
      EPS growth −74%
      Y/Y
      Free cash flow $8.5M
      Buyback $34.0M
      remaining
      Balance sheet $158.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 58%
      annualized · 1-yr
      Max drawdown −60%
      past year
      ATR 7.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 1 of last 2
      Latest guidance · from the 8-K filed Aug 4, 2026
      Core Nutritional business net sales · fiscal year 2026 Initiated $750M
      Hiya net sales · fiscal year 2026 Initiated $125M
      Rise Wellness net sales · fiscal year 2026 Initiated $35M
      Diluted EPS · fiscal year 2026 Initiated $-0.61
      prior FY $0.58 midpoint −205.2% Y/Y
      Consolidated net sales · fiscal year 2026 Lowered $910M
      Jan 12, 2026 $925M – $1B changed to Aug 4, 2026 $910M
      prior FY $925.26M midpoint −1.6% Y/Y
      Adjusted diluted EPS · fiscal year 2026 Initiated $0.76
      Adjusted EBITDA · fiscal year 2026 Initiated $87M
      Consolidated income taxes · fiscal year 2026 Initiated $30M
      Prior guidance period ended · from the 8-K filed Oct 22, 2025
      Consolidated net sales · Fiscal Year 2025 $920M
      Diluted EPS · Fiscal Year 2025 $0.78
      Adjusted Diluted EPS · Fiscal Year 2025 $1.73
      Net sales from the direct selling business · Fiscal Year 2025 $788M
      Net sales from Hiya · Fiscal Year 2025 $132M
      Adjusted EBITDA · Fiscal Year 2025 $98M
      Guided vs delivered · last 2 settled
      Consolidated net sales Fiscal Year 2025
      guided $920M
      $925.26M Beat +0.6%
      Diluted EPS Fiscal Year 2025
      guided $0.78
      $0.58 Miss −25.6%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −32% Bearish
      Price vs 50-day avg
      −32% Bearish
      RSI (14)
      27 Neutral
      MACD trend
      Negative Bearish
      52-week position
      2% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $19 › 200d $19 — 50d above 200d
      Institutional flow Distributing
      -1% holders QoQ · +23 funds added
      Insider flow Distributing
      Net -$524.2K over 90 days · 100% sells
      Short interest Falling
      3.74% of float · ▼ -8.3% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      137 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $13 Now $13 · 2% Range high $32
      vs 200-day avg -32% vs 50-day avg -32%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted diluted EPS non-GAAP -$0.07 Q2 2026 —
      Adjusted net (loss) earnings attributable to USANA non-GAAP -1.24M Quarter ended July 4, 2026 —
      Americas and Europe Region Active Customers 77,000 Q2 2026 —
      Asia Pacific Region Active Customers 307,000 Q2 2026 —
      Free cash flow non-GAAP $20M Quarter ended July 4, 2026 —
      USANA Active Customers 387,000 FY 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Packaged Foods — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      USNA
      Usana Health Sciences Inc
      this stock
      		$243.52M -32.9% -10.8% — 3.7%
      KHC
      Kraft Heinz Co
      		 $30.45B +5.4% -0.1% — 7.3%
      GIS
      General Mills Inc
      		 $21.34B -14.8% +4.1% — 9.2%
      MKC
      Mccormick & Co Inc
      		 $15.18B -18.9% +1.7% 9.4 5.1%
      JBS
      Jbs N.V.
      		 $14.73B -6.0% — — 3.3%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      137
      % held
      61.8%
      Net QoQ
      +1.1M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      185
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      690.3K
      Days to cover
      7.5d
      Change
      -62.7K sh
      View
      Short Volume
      Short vol %
      40%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      719
      Value
      $16.3K
      As of
      Jul 30, 2026
      View
      Off-Exchange
      Off-exchange %
      39.1%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$524.2K
      Buyers / Sellers
      0 / 4
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $925.3M
      Net income (FY)
      $10.8M
      EPS diluted
      $0.58
      View
      Buybacks
      Authorized
      $150.0M
      Remaining
      $34.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 13, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $97.3K
      Shares
      5.0K
      Filed
      Jun 16, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      USNA -3.3% -37.0% -38.8% -40.4% -32.9%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY -1.3% -40.3% -49.9% -42.5% -44.7%

      Capital returns

      Buyback program · as of Aug 4, 2026
      Authorized
      $150.00M
      Spent (derived)
      $116.00M
      Remaining
      $34.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 896264 CUSIP 90328M107 13F (30d) 130 filings 129 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)